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Methods

Conclusions: Inhibition of HSV-1 by Cpn may reflect competition for the
same cellular receptor. Whereas disruption of host cell transcription by
HSV-1 may modify normal Cpn development, Cpn is able to replicate in the
presence of HSV-1.

Introduction

Our ongoing studies investigate the potential role of herpes simplex virus
type 1 (HSV-1) and Chlamydia pneumoniae (Cpn) in the pathogenesis of
neurodegenerative disorders, such as Alzheimer’s disease. Since both HSV-1
and Cpn are ubiquitous and have the ability to persist in a latent state,
with the potential for reactivation to a productive infection, it is
reasonable to postulate that infection by either or both pathogens might
contribute to the gradual accumulation of pathology associated with
neurodegeneration. This current study examines whether an astrocyte cell
line can be simultaneously infected by these two pathogens and if coinfection alters pathogen replication and/or cellular pathology associated
with infection by either pathogen individually.
It is known that both HSV-1 and Cpn can utilize heparin sulfate as
receptors, thus the presence of one pathogen might interfere with
attachment and internalization of the second pathogen. Furthermore, Cpn
enters a state of persistence in response to changes in the host cell
environment and we speculate that productive HSV-1 infection might set up
an intracellular environment that induces persistence in Cpn. It is possible
that both Cpn and HSV-1 might cycle through periods of productive
infection and latency, thereby contributing to progressive neuropathology.
To assess whether the presence of HSV-1 alters Cpn gene expression, the
relative levels of 6 different Cpn genes involved in different stages of the
replication cycle were examined in RNA from cells infected with Cpn alone
or dually infected with Cpn and HSV-1. The genes examined are listed in
Table 1; L-29, TUF, and ABCX have been designated as potential chlamydial
housekeeping genes whose expression remains relatively constant
throughout the replication cycle (1). In this study, we use L-29 as an
endogenous control to normalize quantity of Cpn in the different samples
within an experiment. Immunofluorescence and determination of viral
titers provide additional methodology to further evaluate Cpn or HSV-1
infection of astrocytes.
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Locus
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Gene

Gene description/function

16S

16S ribosomal RNA

lcrH_1

Low calcium response protein H CPn0811 Marks transition from RB to EB

hctA

Histone-like developmental
protein

rpmC

50S ribosomal protein L29

tuf

Elongation factor Tu

Comment
Standard Curve quantification

CPn0886 Marks transition from RB to EB
CPn0639 housekeeping gene candidate
CPn0074 housekeeping gene candidate

euo

Chlamydial repressor protein

abcX

ABC transporter ATPase

CPj0561 Early chlamydial gene
CPn0691 housekeeping gene candidate

Reference
1. Maurer AP, Mehlitz A, Mollenkopf HJ, Meyer TF: Gene expression profiles of
Chlamydophila pneumoniae during the developmental cycle and iron depletion-mediated
persistence. PLoS Pathog 2007, 3(6):e83.

Results
3.5

0.8

3.0

0.9

2.5
Cpn24 hr
2.0

Cpn 48hr
HSV/Cpn 48/48

1.5

HSV/Cpn 48/24
HSV/Cpn 24/48

5
4

0.01
3
2

HSV 24 hr
HSV 48hr
HSV/Cpn 48/48
HSV/Cpn 48/24
HSV/Cpn 24/48

0.001
HSV-1 titers

Relative HSV-1 DNA

Figure 5. Quantification of HSV-1 from infected astrocytes in the presence or
absence of Cpn. Astrocyte monolayers were infected with HSV-1 alone or co-infected
with HSV-1 and Cpn. Viral titers in culture supernates were measured by plaque assay
and expressed as the Log10 (Plaque Forming Units [PFU]/ml). Results represent the
mean and standard deviation from 3 separate experiments. HSV DNA was quantified by
RT-PCR using an HSV-1-specific primer; copy number was calculated from a standard
curve derived from amplification of a known concentration of primer-specific
sequences and expressed relative to that of the 48 hour single HSV-1 infection. Results
represent the mean + SD from 4 separate experiments.

• Single or dual infections contained similar levels of HSV-1 at
48hrs post infection, however, at 24 hours post infection some
inhibition of HSV-1 was observed in monolayers previously
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Figure 1. Quantification of Cpn from infected astrocytes in the
presence or absence of HSV-1. Astrocyte monolayers were infected
with Cpn alone or co-infected with Cpn and HSV-1. Cpn DNA was
quantified by RT-PCR using a Cpn 16S rRNA-specific primer; copy
number was calculated from a standard curve derived from
amplification of a known concentration of primer-specific sequences
and expressed relative to that of the 48 hour single Cpn infection.
Results represent the mean and standard deviation from 4 separate
experiments.
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Figure 3. Expression of Cpn genes from
infected astrocytes in the presence or
absence of HSV-1. Astrocyte monolayers
were infected with Cpn alone or co-infected
with Cpn and HSV-1. Relative expression of
Cpn genes was obtained following RT2-PCR
amplification of RNA from infected
monolayers. To assess differential expression
of Cpn genes in infected astrocytes, L-29 was
used as an endogenous Cpn control.
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Results: IF revealed that cells could be infected with both Cpn and HSV-1.
When infection with HSV-1 is established prior to addition of Cpn, cells
demonstrated punctate labeling for Cpn but the frequency of larger
aggregates of labeling, consistent with chlamydial inclusions, was
diminished. Data reveal that replication of HSV-1 is lessened but not
prevented by Cpn, while Cpn replication does not appear to be inhibited by
HSV-1.
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• Co-infected monolayers had similar levels of Cpn as the 48hr
single infections

Figure 2. Amplification of host genes. RNA derived from single or dually
infected astrocytes was reverse transcribed and equal amounts of cDNA were
amplified with primers specific for GAPDH and actin. Levels of actin and GAPDH
is inversely related to cycle thresholds; expression of these host genes is shown
relative to that of uninfected samples. The longer the bar in the above plot, the
greater the copy number of host gene sequences present in RNA. Results
represent the mean and standard deviation from 2 separate experiments; actin
data was pooled following amplification using 2 different actin-specific primers.

• Cpn genes showed similar levels of expression when normalized
using a Cpn housekeeping gene

Conclusions
• The presence of Cpn may inhibit initial viral attachment
and/or entry
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Methods: The ability of Cpn and HSV-1 to co-infect an astrocyte cell line
was analyzed by immunofluorescent (IF) labeling of infected cells. The
relative levels of Cpn or HSV in different samples was quantified by RTPCR; expression of various Cpn genes associated with stages of Cpn
development was quantified by RT2-PCR. DNA or RNA was derived from cells
infected with Cpn alone, HSV alone, or infected with Cpn and HSV-1.

Relative Cpn copy number

Objectives: Determine whether Cpn and HSV-1 can co-infect cells and
whether HSV-1 induces persistence of Cpn, thereby favoring chronic
infection by Cpn.

Cell Culture: An astrocyte cell line (STTG-1; ATCC) was cultured in RPMI-1640 (RPMI) with 10% heat-inactivated FBS. Cells were maintained at 37°C in
5% CO2. Infections were performed in 12 well plates seeded with 2 x 105 cells per well; astrocytes were infected when monolayers were 50-70%
confluent (5-8 x 106 cells per well).
Infection: Astrocytes were mock infected with RPMI alone, or inoculated with Chlamydia pneumoniae AR-39 (Cpn; ATCC) and/or Herpes simplex virus
1 (HSV-1; ATTC) for 24 or 48 hours. The HSV inoculum was an approximate MOI of 0.2, while the Cpn inoculum was 0.7. Cpn and HSV-1 were allowed to
attach to astrocyte monolayers in 0.3 ml RPMI for 1 hour, after which time the volume was maintained at 1 ml for the duration of the infection. Coinfections included the simultaneous inoculation of HSV-1 and Cpn (HSV/Cpn 48/48) or addition of the second pathogen at 24 hours post infection
(hpi), which allowed one pathogen to establish infection before addition of the second one (HSV/Cpn 48/24 and HSV/Cpn 24/48). Cells from coinfected monolayers were harvested at 48 hpi. A qualitative evaluation of infection by Cpn and HSV-1 was assessed by immunofluorescent labeling for
the two pathogens using antibodies specific for Cpn (Fitzgerald; 61C75-A) and HSV-1 (Abcam; ab9533). In addition, HSV-1 present in culture supernates
of single and dual infections was titered by plaque assay.
Analysis of gene expression: RNA or DNA was isolated from infected and uninfected cell monolayers using Qiagen’s RNeasy Mini Kit or DNA Blood &
Tissue Kit, respectively, following the manufacturer’s directions. RNA was reverse transcribed (Retroscript kit; Ambion), and the expression of Cpn
genes and cellular actin and GAPDH was quantified from RNA by RT2-PCR using TaqMan gene expression assays (Invitrogen/Life Technologies). The Cpn
gene L-29 was used as an endogenous control to assess relative expression of Cpn genes; this gene was designated as a potential housekeeping gene for
Cpn in a prior investigation (1). HSV-1 or Cpn sequences in DNA samples were quantified by RT-PCR using primers specific for HSV-1 or Cpn
(PrimerDesign) following the manufacturer’s recommended protocol.
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Background and Significance: Chlamydia pneumoniae (Cpn) and Herpes
simplex virus type 1 (HSV-1) have been studied as pathogens contributing to
neurodegenerative diseases. Since Cpn and HSV-1 are both ubiquitous,
many individuals presumably are exposed to both pathogens during their
life time. We speculate that the two pathogens act synergistically in
promoting neuropathology.
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Table 1. Identification of select chlamydial genes analyzed in this study.
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• Cpn does not prevent HSV-1 induced cytopathology
• HSV-1 can alter gene expression in astrocytes
• The presence of one pathogen does not prevent intracellular

Figure 4. Immunofluorescent labeling and phase contrast microscopy of astrocytes infected with
HSV-1 and/or Cpn. In the two left columns, infected astrocytes were labeled by immunofluoresence
for HSV-1 (red) and Cpn (green); cell nuclei are in blue. Phase contrast microscopy (third column)
revealed HSV-1-induced syncytia formation and cell rounding at 48 hpi in the presence or absence of
Cpn; minimal HSV-1-induced cellular damage was noted at 24 hpi (data not shown).

• Differential Cpn gene expression is not observed in single vs
dual infections with the genes examined in this study
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